Summary
Serum levels of prealbumin, fibronectin, fibrinogen, α1-acid glycoprotein, C-reactive protein, immunoglobulins, and white blood cell count were prospectively studied in 33 patients affected by polymyalgia rheumatica during the first 45 days of treatment with 6-methylprednisolone. Almost all parameters considered, except for fibronectin and IgM, settled within the normal range fairly quickly, while prealbumin showed a specular course compared with the other reactants. This behavior reflected the improvement of clinical symptoms registered in all patients after steroid treatment. Finally, the genesis of the low baseline prealbumin levels found in polymyalgia rheumatica/giant cell arteritis and their behavior during treatment are discussed.
Similar content being viewed by others
References
Afifi A. A., Azen S. P.: Statistical Analysis: A Computer-Oriented Approach. Academic Press, New York, 1972.
Andersson R., Malmavall B.-E., Bengtsson B.-Å.: Acute phase reactants in the initial phase of giant cell arteritis — Acta med. scand.220, 365, 1986.
Baracos V., Rodemann H. P., Dinarello C. H., Goldberg A. L.: Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1) — New Engl. J. Med.308, 553, 1983.
Beisel W. R.: Mediators of fever and muscle proteolysis — New Engl. J. Med.308, 586, 1983.
Benson M. D., Dwulet F. E.: Prealbumin and retinol-binding protein serum concentrations in the Indiana type hereditary amyloidosis — Arthrit. Rheumat.26, 1493, 1983.
Bird H. A., Esselinckx W., Dixon A. St. J., Mowat G.: An evaluation of criteria for polymyalgia rheumatica — Ann. rheumat. Dis.38, 434, 1979.
Blake C. C. F., Geisow M. J., Oatley S. J., Rerat C., Rerat B.: Structure of prealbumin: secondary, tertiary, and quaternary interactions determined by Fourier refinement — J. molec. Biol.121, 339, 1978.
Blake C. C. F., Geisow M. J., Swan I. D. A., Rerat C., Rerat B.: Structure of human plasma prealbumin at 2.5 A. A preliminary report on the polypeptide chain conformation, quaternary structure, and thyroxine binding — J. molec. Biol.88, 1, 1974.
Bottiger L. E., Svedberg C. A.: Normal erythrocyte sedimentation rate and age — Brit. med. J.ii, 85, 1967.
Bridgeford P. H., Germain B. F., Lowenstein M., Vasey F. B., Espinoza L. R.: Low erythrocyte sedimentation rate (ESR) in polymyalgia rheumatica — Arthrit. Rheumat.25, S31, 1982. (Abstract).
Chopin N., Geller A., Alexandre J., Dumont G., Befidi R., Lastras J., Lenoir G.: Influence de l’âge sur la concentration sérique des protéines RBP-TBPA et transferrine — Presse méd.12, 959, 1983.
Connors L. H., Gertz M. A., Skinner M., Cohen A. S.: Nephelometric measurement of human serum prealbumin and correlation with acute phase protein CRP and SAA: results in familial amyloid polyneuropathy — J. Lab. clin. Med.104, 538, 1984.
Dickson P. W., Howlett G. J., Schreiber G.: Metabolism of prealbumin in rats and changes induced by acute inflammation — Europ. J. Biochem.129, 289, 1982.
Ellis M. E., Ralston S.: The erythrocyte sedimentation rate in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome — Ann. rheumat. Dis.42, 168, 1983.
Fex G., Felding P.: Factors affecting the concentration of free holoretinol-binding protein in human plasma — Europ. J. clin. Invest.14, 146, 1984.
Freedman D., Pisani R., Purves R.: Statistics. W. W. Norton and Co., New York, 1980.
Gibbs P.: Polymyalgia rheumatica and liver disease — Lanceti, 351, 1974.
Goldsmith B. M., Munson S.: Rate nephelometry and radial immunodiffusion compared for measuring serum prealbumin — Clin. Chem.33, 161, 1987.
Hallen J., Laurell C.-B.: Plasma protein pattern in cirrhosis of the liver — Scand. J. clin. Lab. Invest.29 (Suppl. 124), 97, 1972.
Healey L. A., Wilske K. R.: Manifestation of giant cell arteritis — Med. Clin. N. Amer.61, 261, 1977.
Helliwell M., Coombes E. J., Moody B. J., Batstone G. F.: Thyroxine-binding prealbumin as an index of disease activity or nutritional status in rheumatoid arthritis — Brit. J. Rheumatol.23, 89, 1984.
Huston K. A., Hunder G. G., Lie J. T., Kennedy R. H., Elrebech L. R.: Temporal arteritis: a 25-year epidemiological, clinical and pathological study — Ann. intern. Med.88, 162, 1978.
Ingbar S. H.: Prealbumin: a thyroxine-binding protein of human plasma — Endocrinology63, 256, 1958.
Jones J. G., Hazleman B. L.: Prognosis and management of polymyalgia rheumatica — Ann. rheumat. Dis.40, 1, 1981.
Jouquan J., Pennec Y., Mottier D., Boles J. M., Morin J. F., Youinou P., Garre M.: Protéine vectrice du rétinole, préalbumine et transferrine — Presse méd.12, 1877, 1983.
Kanai M., Raz A., Goodman D. S.: Retinol-binding protein: the transport protein for vitamin A in human plasma — J. clin. Invest.47, 2025, 1968.
Knorring V. J., Wasastjerna C.: Liver involvement in polymyalgia rheumatica — Scand. J. Rheumatol.5, 197, 1976.
Litherland P. G. H., Bromage N. R., Hall R. A.: Thyroxine-binding globulin (TBG) and thyroxine-binding prealbumin (TBPA) measurement, compared with the conventional T3 uptake in the diagnosis of thyroid disease — Clin. chim. Acta122, 345, 1982.
Mallya R. K., Hind C. R. K., Berry H., Pepys M. B.: Serum C-reactive protein in polymyalgia rheumatica: a prospective serial study — Arthrit. Rheumat.28, 383, 1985.
McKone T. K., Davis A. T., Dean R. E.: Fibronectin. A new nutritional parameter — Amer. Surg.51, 336, 1985.
Park J. R., Jones J. G., Hazleman B. L.: Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis — Ann. rheumat. Dis.40, 493, 1981.
Richter M., Coughlan R., Panayi G., Gordon Y.: Is there more than one signal for an acute phase response? — J. Rheumatol.12, 1048, 1985.
Richter M., Coughlan R., Trull A., Panayi G. S.: Prealbumin as a sensitive measure of disease activity — Ann. rheumat. Dis.42, 220, 1983. (Abstract).
Richter M. B., Woo P., Panayi G. S., Trull A., Hunger A., Shepherd P.: The effect of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis — Clin. exp. Immunol.53, 51, 1983.
Scott R. L., Sohmer P. R., MacDonald M. B. G.: The effect of starvation and repletion on plasma fibronectin in man — J. Amer. med. Ass.248, 2025, 1982.
Shetty P. S., Watrasiewicz K. E., Jung R. T., James W. P. T.: Rapid-turnover transport proteins: an index of subclinical protein-energy malnutrition — Lancetii, 230, 1979.
Skredf S., Blomhoff J. P., Elgjo K., Gjone E.: Serum proteins in diseases of the liver — Scand. J. clin. Lab. Invest.35, 399, 1975.
Smith F. R., Goodman D. S.: The effect of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma — J. clin. Invest.50, 2426, 1971.
Soelberg-Sorensen P., Lorenzen I.: Giant cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients — Acta med. scand.201, 207, 1977.
Sokolov E. L., Woeber K. A., Purdy R. H., Holloway M. T., Ingbar S. H.: Preparation of I131-labeled human serum prealbumin and its metabolism in normal and sick patients — J. clin. Invest.44, 1600, 1965.
Teppo A. M., Maury C. P. J.: Serum prealbumin, transferrin and immunoglobulins in fatty liver, alcoholic cirrhosis and primary biliary cirrhosis — Clin. chim. Acta129, 279, 1983.
Winer B. J.: Statistical Principles in Experimental Design. McGraw-Hill, New York, 1971.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Puccetti, L., Lucchetti, A., Barbieri, P. et al. Behavior of prealbumin in the acute phase of polymyalgia rheumatica treated with 6-methylprednisolone. Res. Clin. Lab. 19, 251–258 (1989). https://doi.org/10.1007/BF02871814
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02871814